Surgery Websites
Vascular Surgery Integrated Residency »  Faculty »  UCSF Clinical Faculty »  Peter A. Schneider, M.D.
Peter A. Schneider, M.D.

Peter A. Schneider, M.D.

Professor of Surgery
Division of Vascular & Endovascular Surgery

Contact Information

Division of Vascular and Endovascular Surgery
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
peter.schneider@ucsf.edu
Open Popup

The Johns Hopkins University School of Medicine Five-Year BA-MD Curriculum, The Johns Hopkins University, Baltimore, MD, Class of 1983

Undergraduate, University of California San Diego, La Jolla, CA, 1976-1978



  • University of California San Francisco, San Francisco, CA
  • Resident in General Surgery, June, 1983 to June, 1986 and July, 1988 to June, 1989
  • Chief Resident in General Surgery, July, 1989 to June, 1990
  • Research Fellowship: Roon Center of Arteriosclerosis and Thrombosis, Department of Basic Research and Noninvasive Vascular Diagnostic Laboratory, Scripps Clinic and Research Foundation, La Jolla, CA, July, 1986 to June, 1988
  • Clinical Fellowship: University of California San Francisco, San Francisco, CA, Clinical Fellow in Vascular Surgery, July, 1990 to June, 1991
  • American Board of Surgery, Vascular Surgery
  • Abdominal Aortic Aneurysm
  • Carotid Artery Disease
  • Complex Limb Revascularization
  • Critical Limb Ischemia
  • Diabetic Vascular Disease
  • Dialysis Access
  • Endovascular Aneurysm Repair
  • Mesenteric Artery Disease
  • Peripheral Artery Disease
  • Thoracic Aortic Aneurysm
  • Thoracic Outlet Syndrome

Peter A. Schneider, M.D. is Professor of Surgery in the Division of Vascular & Endovascular Surgery at University of California San Francisco. Dr. Schneider received his MD from the Johns Hopkins School of Medicine and completed his general surgery residency and vascular surgery fellowship at the University of California San Francisco.

Dr. Schneider was the founding member and chief of the Division of Vascular Surgery at Kaiser Permanente in Hawaii from 1994-2018. At Kaiser, he helped to develop a Diabetic Limb Treatment Program and a surveillance program for patients with aneurysms and a registry for patients with carotid disease used for surveillance. He oversaw the development of the first endovascular operating room in the Kaiser system.

Dr. Schneider has served on numerous committees for the Society for Vascular Surgery and is the past president of Western Vascular Society where he also served on a number of its committees. He has been invited to numerous visiting professorships and has served as faculty or course director for many specialty courses. He authored "Endovascular Skills," the 4th edition, to be published in 2019, and has co-authored three other books on various aspects of vascular surgery. Dr. Schneider founded two medical device companies, served as an adviser to many others, and has been awarded numerous patents.

Dr. Schneider is a Distinguished Fellow of the Society for Vascular Surgery.

Dr. Schneider has served as National Principal Investigator for numerous clinical trials. Over 25 years, he has been a strong proponent of clinical research in vascular disease and has participated extensively in trial design, oversight, core lab analysis, events committees, data analysis, follow up, presentation, and publication. He has consulted on the regulatory pathway and pivotal trials for many vascular devices, has participated in numerous meetings with the FDA and has testified at FDA panel hearings. His experience includes performing procedures for several first-in-human trials. 

MOST RECENT PUBLICATIONS FROM A TOTAL OF 93
Data provided by UCSF Profiles, powered by CTSI
  1. Giannopoulos S, Strobel A, Rudofker E, Kovach C, Schneider PA, Armstrong EJ. Association of Postangioplasty Femoropopliteal Dissections With Outcomes After Drug-Coated Balloon Angioplasty in the Femoropopliteal Arteries. J Endovasc Ther. 2021 May 18; 15266028211016441. View in PubMed
  2. Clair DG, Mustapha JA, Shishehbor MH, Schneider PA, Henao S, Bernardo NN, Deaton DH. PROMISE I early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia 12-month results. J Vasc Surg. 2021 May 18. View in PubMed
  3. Ramirez JL, Lopez J, Sanders K, Schneider PA, Gasper WJ, Conte MS, Sosa JA, Iannuzzi JC. Understanding Value and Patient Complexity Among Common Inpatient Vascular Surgery Procedures. J Vasc Surg. 2021 Apr 19. View in PubMed
  4. Ramirez JL, Smith EJT, Zarkowsky DS, Lopez J, Hicks CW, Schneider PA, Conte MS, Iannuzzi JC. Closure Device Use for Common Femoral Artery Antegrade Access is Higher Risk than Retrograde Access. Ann Vasc Surg. 2021 Apr 07. View in PubMed
  5. El Khoury R, Wu B, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS. The Global Limb Anatomic Staging System (GLASS) is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia. J Vasc Surg. 2021 Feb 03. View in PubMed
  6. View All Publications

 

Site Directory
    X